Gerardo Hernandez
Fortuna: 3 M $ al 31/08/2026
Fortuna: 3 M $ al 31/08/2026
Mr. Gerardo Hernandez was previously employed as a Chief Financial Officer & Treasurer by TransMedics Group, Inc. and a VP-Finance & Head-Financial Planning & Analysis by Alnylam Pharmaceuticals, Inc. He received his undergraduate degree from the University of Wisconsin La Crosse and an MBA from Escola de Administração de Empresas de São Paulo.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TRANSMEDICS GROUP, INC. 0,09 % | 10/07/2026 | 31.935 ( 0,09 % ) | 3 M $ | 31/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Director Financiero/CFO | 21/09/2026 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Escola de Administração de Empresas de São Paulo
Escola de Administração de Empresas de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin La Crosse
University of Wisconsin La Crosse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.